Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 26 11 2018
revised: 09 02 2019
accepted: 01 03 2019
pubmed: 8 3 2019
medline: 18 12 2019
entrez: 8 3 2019
Statut: ppublish

Résumé

Extended molecular characterization of HLA genes in the IHWG reference B-lymphoblastoid cell lines (B-LCLs) was one of the major goals for the 17th International HLA and Immunogenetics Workshop (IHIW). Although reference B-LCLs have been examined extensively in previous workshops complete high-resolution typing was not completed for all the classical class I and class II HLA genes. To address this, we conducted a single-blind study where select panels of B-LCL genomic DNA samples were distributed to multiple laboratories for HLA genotyping by next-generation sequencing methods. Identical cell panels comprised of 24 and 346 samples were distributed and typed by at least four laboratories in order to derive accurate consensus HLA genotypes. Overall concordance rates calculated at both 2- and 4-field allele-level resolutions ranged from 90.4% to 100%. Concordance for the class I genes ranged from 91.7 to 100%, whereas concordance for class II genes was variable; the lowest observed at HLA-DRB3 (84.2%). At the maximum allele-resolution 78 B-LCLs were defined as homozygous for all 11 loci. We identified 11 novel exon polymorphisms in the entire cell panel. A comparison of the B-LCLs NGS HLA genotypes with the HLA genotypes catalogued in the IPD-IMGT/HLA Database Cell Repository, revealed an overall allele match at 68.4%. Typing discrepancies between the two datasets were mostly due to the lower-resolution historical typing methods resulting in incomplete HLA genotypes for some samples listed in the IPD-IMGT/HLA Database Cell Repository. Our approach of multiple-laboratory NGS HLA typing of the B-LCLs has provided accurate genotyping data. The data generated by the tremendous collaborative efforts of the 17th IHIW participants is useful for updating the current cell and sequence databases and will be a valuable resource for future studies.

Identifiants

pubmed: 30844424
pii: S0198-8859(19)30227-7
doi: 10.1016/j.humimm.2019.03.001
pmc: PMC6599558
mid: NIHMS1024233
pii:
doi:

Substances chimiques

HLA Antigens 0
Histocompatibility Antigens Class I 0
Histocompatibility Antigens Class II 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

449-460

Subventions

Organisme : NINDS NIH HHS
ID : U19 NS095774
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Références

Tissue Antigens. 1999 May;53(5):486-97
pubmed: 10372544
Rev Immunogenet. 1999;1(2):177-208
pubmed: 11253946
J Mol Evol. 2002 Dec;55(6):718-26
pubmed: 12486530
J Immunol. 1992 Mar 15;148(6):1941-8
pubmed: 1541831
Genes Immun. 2006 Sep;7(6):450-67
pubmed: 16791278
Hum Immunol. 2011 Oct;72(10):859-68
pubmed: 21664941
Tissue Antigens. 2012 Jul;80(1):1-11
pubmed: 22651253
Int J Immunogenet. 2013 Feb;40(1):1
pubmed: 23280276
Tissue Antigens. 2013 Apr;81(4):194-203
pubmed: 23510415
Tissue Antigens. 2013 Aug;82(2):106-12
pubmed: 23849068
Tissue Antigens. 2014 Sep;84(3):293-303
pubmed: 24962621
Nucleic Acids Res. 2015 Jan;43(Database issue):D423-31
pubmed: 25414341
PLoS One. 2015 May 27;10(5):e0127153
pubmed: 26018555
Immunogenetics. 2015 Sep;67(9):479-85
pubmed: 26198775
Hum Immunol. 2016 Mar;77(3):249-256
pubmed: 26621609
Am J Hum Genet. 2016 Aug 4;99(2):375-91
pubmed: 27486779
HLA. 2018 Feb;91(2):88-101
pubmed: 29171935
Hum Immunol. 2018 Feb;79(2):77-86
pubmed: 29247682
J Immunol. 1987 Mar 15;138(6):1657-9
pubmed: 3819393
Tissue Antigens. 1995 Jan;45(1):1-11
pubmed: 7725305
Tissue Antigens. 1995 Nov;46(5):355-67
pubmed: 8838344
Tissue Antigens. 1997 Aug;50(2):178-91
pubmed: 9271828
Front Biosci. 1998 Jul 27;3:d739-45
pubmed: 9675159

Auteurs

Lisa E Creary (LE)

Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA. Electronic address: lcreary@stanford.edu.

Sandra G Guerra (SG)

Histocompatibility and Immunogenetics Service Development Laboratory, NHS Blood and Transplant, London, UK.

Winnie Chong (W)

Histocompatibility and Immunogenetics Service Development Laboratory, NHS Blood and Transplant, London, UK.

Colin J Brown (CJ)

Department of Histocompatibility and Immunogenetics, NHS Blood and Transplant, London, UK.

Thomas R Turner (TR)

Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.

James Robinson (J)

Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.

Will P Bultitude (WP)

Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.

Neema P Mayor (NP)

Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.

Steven G E Marsh (SGE)

Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.

Katsuyuki Saito (K)

Molecular Biology Research Department, One Lambda, Thermo Fisher Scientific, Canoga Park, CA, USA.

Kevin Lam (K)

Molecular Biology Research Department, One Lambda, Thermo Fisher Scientific, Canoga Park, CA, USA.

Jamie L Duke (JL)

Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Timothy L Mosbruger (TL)

Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Deborah Ferriola (D)

Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Dimitrios Monos (D)

Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Lab Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Amanda Willis (A)

Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, USA.

Medhat Askar (M)

Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, USA.

Gottfried Fischer (G)

Department for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.

Chee Loong Saw (CL)

HLA Laboratory, Division of Haematology, McGill University Health Centre, Montreal, Canada.

Jiannis Ragoussis (J)

Department of Human Genetics, McGill University & McGill University and Genome Quèbec Innovation Centre, Montreal, Canada.

Martin Petrek (M)

Department of Pathological Physiology and Immunogenomics, IMTM, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.

Carles Serra-Pagés (C)

Immunology Department, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.

Manel Juan (M)

Immunology Department, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.

Catherine Stavropoulos-Giokas (C)

Biomedical Research Foundation Academy of Athens, Hellenic Cord Blood Bank, Athens, Greece.

Amalia Dinou (A)

Biomedical Research Foundation Academy of Athens, Hellenic Cord Blood Bank, Athens, Greece.

Reem Ameen (R)

Health Sciences Center, Kuwait University, Kuwait.

Salem Al Shemmari (S)

Health Sciences Center, Kuwait University, Kuwait.

Eric Spierings (E)

Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands.

Ketevan Gendzekhadze (K)

HLA Laboratory, City of Hope, Duarte, CA, USA.

Gerald P Morris (GP)

Department of Pathology, University of California San Diego, La Jolla, CA, USA.

Qiuheng Zhang (Q)

Department of Pathology and Laboratory Medicine, UCLA Immunogenetics Center, Los Angeles, CA, USA.

Zahra Kashi (Z)

HLA Department, Kashi Clinical Laboratories, Inc., Portland, OR, USA.

Susan Hsu (S)

HLA Laboratory, American Red Cross, Philadelphia, PA, USA.

Sridevi Gangavarapu (S)

Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Kalyan C Mallempati (KC)

Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Fumiko Yamamoto (F)

Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Kazutoyo Osoegawa (K)

Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Tamara Vayntrub (T)

Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Chia-Jung Chang (CJ)

Stanford Genome Technology Center, Palo Alto, CA, USA.

John A Hansen (JA)

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Marcelo A Fernández-Viňa (MA)

Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH